MedPath

NITROLINGUAL

These highlights do not include all the information needed to use NITROLINGUAL® PUMPSPRAY safely and effectively. See full prescribing information for NITROLINGUAL PUMPSPRAY. NITROLINGUAL® PUMPSPRAY (nitroglycerin) lingual spray Initial U.S. Approval: 1997

Approved
Approval ID

2b7c772a-adef-4eef-bb83-aaa798e1b712

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 7, 2018

Manufacturers
FDA

Espero Pharmaceuticals, Inc.

DUNS: 079905661

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Nitroglycerin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70007-300
Application NumberNDA018705
Product Classification
M
Marketing Category
C73594
G
Generic Name
Nitroglycerin
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 21, 2017
FDA Product Classification

INGREDIENTS (6)

NITROGLYCERINActive
Quantity: 400 ug in 1 1
Code: G59M7S0WS3
Classification: ACTIB
MEDIUM-CHAIN TRIGLYCERIDESInactive
Code: C9H2L21V7U
Classification: IACT
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
PEPPERMINT OILInactive
Code: AV092KU4JH
Classification: IACT
LACTIC ACIDInactive
Code: 33X04XA5AT
Classification: IACT
SODIUM LACTATEInactive
Code: TU7HW0W0QT
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NITROLINGUAL - FDA Drug Approval Details